Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL055709-02
Application #
2234339
Study Section
Special Emphasis Panel (ZHL1-CSR-Q (S2))
Project Start
1995-09-30
Project End
1999-08-31
Budget Start
1996-09-01
Budget End
1997-08-31
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02215
Schmaier, Alvin H (2008) The elusive physiologic role of Factor XII. J Clin Invest 118:3006-9
Nieman, M T; Burke, F; Warnock, M et al. (2008) Thrombostatin FM compounds: direct thrombin inhibitors - mechanism of action in vitro and in vivo. J Thromb Haemost 6:837-45
Schmaier, A H; McCrae, K R (2007) The plasma kallikrein-kinin system: its evolution from contact activation. J Thromb Haemost 5:2323-9
Schmaier, A H (2000) Plasma kallikrein/kinin system: a revised hypothesis for its activation and its physiologic contributions. Curr Opin Hematol 7:261-5
Pan, L; Teshima, T; Hill, G R et al. (1999) Granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation maintains graft-versus-leukemia effects through a perforin-dependent pathway while preventing graft-versus-host disease. Blood 93:4071-8
Rebel, V I; Tanaka, M; Lee, J S et al. (1999) One-day ex vivo culture allows effective gene transfer into human nonobese diabetic/severe combined immune-deficient repopulating cells using high-titer vesicular stomatitis virus G protein pseudotyped retrovirus. Blood 93:2217-24
Schmaier, A H; Rojkjaer, R; Shariat-Madar, Z (1999) Activation of the plasma kallikrein/kinin system on cells: a revised hypothesis. Thromb Haemost 82:226-33
Rebel, V I; Hartnett, S; Hill, G R et al. (1999) Essential role for the p55 tumor necrosis factor receptor in regulating hematopoiesis at a stem cell level. J Exp Med 190:1493-504
Pan, L; Bressler, S; Cooke, K R et al. (1996) Long-term engraftment, graft-vs.-host disease, and immunologic reconstitution after experimental transplantation of allogeneic peripheral blood cells from G-CSF-treated donors. Biol Blood Marrow Transplant 2:126-33
Pan, L; Delmonte Jr, J; Jalonen, C K et al. (1995) Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease. Blood 86:4422-9